Georges Nakhoul

Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease

Georges Nakhoul, Haiquan Huang, Susana Arrigain et al. · American Journal of Nephrology · 2015 · 167 citations · Full text

Medicine, Nephrology, Dialysis +16

Geographic Trends, Patient Characteristics, and Outcomes of Infective Endocarditis Associated With Drug Abuse in the United States From 2002 to 2016

Amer N. Kadri, Bryan Wilner, Adrían V. Hernández et al. · Journal of the American Heart Association · 2019 · 148 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +16

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Barriers to accessing essential medicines for kidney disease in low- and lower middle–income countries|

Anna Francis, Muhammad Iqbal Abdul Hafidz, Udeme E. Ekrikpo et al. · Kidney International · 2022 · 66 citations · Full text

Pharmacy, Nephrology, Pharmacoeconomics +15